PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-24.85%
Both yoy net incomes decline, with ORCL at -2.55%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
10.56%
Some D&A expansion while ORCL is negative at -1.74%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
242.11%
Some yoy growth while ORCL is negative at -13.21%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
2.13%
SBC growth well above ORCL's 2.76%. Michael Burry would flag major dilution risk vs. competitor’s approach.
51.99%
Less working capital growth vs. ORCL's 117.35%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
173.38%
AR growth well above ORCL's 124.63%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-78.17%
Negative yoy inventory while ORCL is 136.36%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-134.96%
Both negative yoy AP, with ORCL at -82.19%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
11.79%
Lower 'other working capital' growth vs. ORCL's 109.02%. David Dodd would see fewer unexpected short-term demands on cash.
-2.07%
Both negative yoy, with ORCL at -4.84%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
85.19%
Operating cash flow growth below 50% of ORCL's 593.41%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-14.03%
Both yoy lines negative, with ORCL at -88.72%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-46.72%
Both yoy lines negative, with ORCL at -12.93%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
21.32%
Purchases well above ORCL's 34.48%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-26.09%
Both yoy lines are negative, with ORCL at -64.03%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-123.16%
Both yoy lines negative, with ORCL at -103.44%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-64.75%
Both yoy lines negative, with ORCL at -116.65%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-643.80%
We cut debt repayment yoy while ORCL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
35.90%
We slightly raise equity while ORCL is negative at -52.91%. John Neff sees competitor possibly preserving share count or buying back shares.
-4.87%
We cut yoy buybacks while ORCL is 35.24%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.